Cannabinoids and Neurodegenerative
1: Navarro G, Morales P, Rodríguez-Cueto C, Fernández-Ruiz J, Jagerovic N, Franco R. Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders. Front Neurosci.
2: Mickael ME, Rajput A, Steyn J, Wiemerslage L, Bürglin T. An optimised phylogenetic method sheds more light on the main branching events of rhodopsin-like superfamily. Comp Biochem Physiol Part D Genomics Proteomics.
3: Jayant S, Sharma B. Selective modulator of cannabinoid receptor type 2 (CB2) against biochemical alterations and brain damage in chronic cerebral hypoperfusion induced vascular dementia. Curr Neurovasc Res.
4: Clark IA, Vissel B. Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents. J Neuroinflammation.